California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva found liable for fueling opioid addiction in New York
Report: Teva Settles Investor Lawsuit for $420M - Hamodia.com
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva wins opioids case in California court - Globes
States bring price fixing lawsuit against Teva and other drug makers | Healthcare Finance News
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace
Teva Loses New York Lawsuit over Painkillers – Stock Plummets - Jewish Business News
Bausch Health resolves IP litigation with Teva
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva Pharmaceuticals Retirement Savings Plan Class Action Lawsuit
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | FiercePharma
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva Pharmaceuticals Faces FCA Lawsuit Over Illegal Kickbacks, Company Stocks Drop by 10%
Teva's generic label not skinny enough to protect from $234M damages to GSK - MedCity News
